Search results for "Bone Marrow"

showing 10 items of 538 documents

Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myelo…

2009

Abstract Abstract 2803 Poster Board II-779 Background. The rate of asymptomatic amyloidosis (asym-amyloidosis) detected in patients with newly diagnosed multiple myeloma (MM) or smoldering multiple myeloma (SMM) is unknown. This topic is significant because unrecognized AL may be associated with increased mortality may change the patient's management. The objective of the present investigation was to evaluate the number and clinical significance of asym-amyloidosis in MM and SM patients at the time of the diagnostic bone marrow (BM) biopsy for MM. Materials and Methods. The study population was selected from the Mayo Clinic Dysproteinemia database and consisted of consecutive patients with …

amyloidosisProthrombin timemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryAmyloidosisImmunologyCell BiologyHematologymedicine.diseaseBiochemistryAsymptomaticGastroenterologySettore MED/15 - Malattie Del SangueSurgerymedicine.anatomical_structureInternal medicineBiopsymedicineClinical significanceBone marrowmedicine.symptomMyelofibrosisbusinessMultiple myelomaBlood
researchProduct

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is…

2006

BACKGROUND AND OBJECTIVES: This European Group for Blood and Marrow Transplantation (EBMT) multicentre randomized phase III study was designed to assess the safety and efficacy of CD34+ selection in newly diagnosed myeloma patients undergoing autologous transplantation. DESIGN AND METHODS: One hundred and eleven patients responsive to initial chemotherapy were randomized to receive CD34+ selected (arm A) or unselected PBPC (arm B) after conditioning with high-dose melphalan and TBI. ASO-PCR was used to assess purging efficacy and reinfused tumor load. Tumor load could be assessed in 59 patients. RESULTS: CD34+ selection gave a median tumor cell depletion of 2.2 logs (0.77-5.96). No tumor ce…

autologous transplantMelphalanOncologyAdultMaleRiskmedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentAntigens CD34Transplantation AutologousDexamethasoneDisease-Free SurvivalPostoperative ComplicationsRecurrenceInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineEuropean Group for Blood and Marrow TransplantatioAutologous transplantationHumansSurvival rateSurvival analysisMultiple myelomaAgedChemotherapyPeripheral Blood Stem Cell TransplantationHematologybusiness.industryBone Marrow PurgingHematologyCD34+ selectionMiddle Agedmedicine.diseasePrognosisSurvival AnalysisBone marrow purgingSurgerySurvival RateTreatment OutcomeDoxorubicinVincristineFemalebusinessMultiple Myelomamedicine.drugFollow-Up StudiesHaematologica
researchProduct

Inhibition of Lymphocyte Proliferation during Parasitic Infection with Nippostrongylus Brasiliensis

1979

It is now well established that parasitic infections can lead to the production of high titers of IgE anti parasitic antibodies in experimental animals and in man (1,2). One of the best studied experimental systems involves the ability of the nematode parasite Nippostrongylus brasiliensis (N.B.) to stimulate a high titer reaginic antibody response to worm antigens in the rat. These studies were extended by the reports of Orr and Blair that parasitic infections can cause non specific proliferation of IgE antibody response against antigens unrelated to those of the parasite (3). The amplification of an already existing IgE antibody response can be induced before infection by inoculating the a…

biologymedicine.medical_treatmentLymphocyte proliferationImmunoglobulin Ebiology.organism_classificationTitermedicine.anatomical_structureAntigenImmunologybiology.proteinmedicineBone marrowNippostrongylus brasiliensisAntibodyAdjuvant
researchProduct

Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again

2023

Multiple myeloma (MM) is an incurable hematologic malignancy characterized by a multistep evolutionary pathway, with an initial phase called monoclonal gammopathy of undetermined significance (MGUS), potentially evolving into the symptomatic disease, often preceded by an intermediate phase called “smoldering” MM (sMM). From a biological point of view, genomic alterations (translocations/deletions/mutations) are already present at the MGUS phase, thus rendering their role in disease evolution questionable. On the other hand, we currently know that changes in the bone marrow microenvironment (TME) could play a key role in MM evolution through a progressive shift towards a pro-inflammatory and…

bone marrow microenvironmentmultiple myelomatumor associated immune cellssmoldering myelomaHematologymonoclonal gammopathy of undetermined significanceHematology Reports
researchProduct

Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs).

2019

Adipose tissue is now on the top one of stem cell sources regarding its accessibility, abundance, and less painful collection procedure when compared to other sources. The adipose derived stem cells (ADSCs) that it contains can be maintained and expanded in culture for long periods of time without losing their differentiation capacity, leading to large cell quantities being increasingly used in cell therapy purposes. Many reports showed that ADSCs-based cell therapy products demonstrated optimal efficacy and efficiency in some clinical indications for both autologous and allogeneic purposes, hence becoming considered as potential tools for replacing, repairing, and regenerating dead or dama…

bone marrowmedicine.medical_treatmentAdipose tissueregenerative medicineBone Marrow CellsReviewMesenchymal Stem Cell TransplantationRegenerative medicinestem cell therapyCatalysisUmbilical CordInorganic ChemistryCell therapylcsh:ChemistryADSCsMedicineAnimalsHumansPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5Spectroscopymesenchymal stem cellsbusiness.industryOrganic ChemistryMesenchymal stem cellCell DifferentiationGeneral MedicineStem-cell therapyStromal vascular fractionComputer Science Applicationsadipose tissueadipose derived stem cellsmedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Cancer researchBone marrowStem cellbusinessInternational journal of molecular sciences
researchProduct

Identification and characterization of the somatic stem cell niche in the human endometrium

2013

El endometrio es la capa de mucosa que recubre el interior del útero y consiste en un epitelio simple cilíndrico con o sin cilios, glándulas y un estroma rico en tejido conjuntivo y altamente vascularizado. Durante cada ciclo menstrual, el endometrio sufre una serie de cambios en respuesta a fluctuaciones en los niveles de las hormonas esteroideas procedentes del ovario. El endometrio se divide histológicamente en dos capas, la capa basal, la cual ni responde a las hormonas esteroideas ni sufre descamación, pudiendo regenerar una nueva capa funcional en el siguiente ciclo menstrual. Mientras que la capa funcional si responde tanto a la progesterona como el estradiol, descamándose durante la…

bone marrowstem cellsUNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología de la reproducción:CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología de la reproducción [UNESCO]human endometrium
researchProduct

Kaulu smadzenu mononukleāro šūnu daudzumuun kvalitātiietekmējošie faktori cela locītavas osteoartrīta pacientiem

2020

Osteoartrīts ir visizplatītākā locītavu slimība ar ievērojamām ekonomiskām izmaksām un pieaugošu izplatību (Conaghan et al. 2014). Viena no galvenajām problēmām ir tā, ka nav nekādas ārstēšanas, izņemot locītavas aizvietošanu, kas var izārstēt osteoartrītu, tāpēc ir svarīgi izpētīt alternatīvas ārstēšanas metodes, piemēram, cilmes šūnu terapiju. Interese par mononukleāro šūnu izpēti kā ārstēšanas metodi ir plaši pieaugusi, bet vēl tikai nedaudz ir zināms par optimālo ievadīto mononukleāro šūnu daudzumu un par to, kāpēc mononukleāro un mezenhimālo cilmes šūnu daudzums un kvalitāte cilvēkiem ir atšķirīga. Pētījuma mērķis ir noskaidrot, vai starp pacientu faktoriem, piemēram, vecumu, dzimumu, …

bone marrowstem cellsarticular cartilageknee osteoarthritisMedicīnamononuclear cells
researchProduct

Immunological micro and macroenvironment modifications for the early diagnosis and prognostication of breast and prostate adenocarcinomas

breast cancerbone marrowTumor microenvironmentmouse modeltumor macroenvironmentprostate cancermast cell
researchProduct

Investigation of inhibitory effects on EPC-mediated neovascularization by different bisphosphonates for cancer therapy.

2013

Bisphosphonates (BPs) are potent drugs, used in metastatic cancer-like prostate or breast carcinoma. In recent studies, besides reduced bone remodeling, influences on angiogenesis and neovascularization were reported. Since BPs have the tendency to accumulate in the bones, the biological effect of various nitrogen- and non-nitrogen BPs on endothelial progenitor cells (EPCs) that originated from bone marrow and mobilized under physiological and pathophysiological conditions, such as tumor neovascularization, was investigated. EPCs subsequent to 72-h treatment with different concentrations of bisphosphonates comprised the non-nitrogen-containing BP clodronate and the nitrogen-containing BPs i…

business.industryAngiogenesisGeneral Neurosciencemedicine.medical_treatmentContext (language use)General MedicineArticlesBisphosphonateurologic and male genital diseasesEndothelial progenitor cellGeneral Biochemistry Genetics and Molecular BiologyBone remodelingNeovascularizationmedicine.anatomical_structureImmunologymedicineCancer researchBone marrowGeneral Pharmacology Toxicology and Pharmaceuticsmedicine.symptomProgenitor cellbusinesshormones hormone substitutes and hormone antagonistsBiomedical reports
researchProduct

Mechanisms of Autocrine and Paracrine Growth Control in Acute Myelogenous Leukemia

1990

Blast cells of a high proportion of patients with acute myelogenous leukemia (AML) proliferate in response to exogenous hematopoetic growth factors, both in vitro [9, 14, 26, 36, 48, 65] and in vivo [20]. Whereas leukemic colony-forming cells (L-CFCs) from most patients share their growth factor dependence with normal committed myeloid progenitor cells (CFU-GMs), some AML samples autonomously form colonies in agar and are therefore believed to bypass growth factor requirements [17, 42, 72]. Autocrine growth factor production has been identified as one mechanism used by AML blasts to supply various growth-promoting molecules. Moreover nontransformed accessory bone marrow cells have been show…

business.industryGrowth factormedicine.medical_treatmentmedicine.diseaseColony-stimulating factorMyelogenousLeukemiaParacrine signallingmedicine.anatomical_structureCytokinehemic and lymphatic diseasesImmunologymedicineCancer researchBone marrowAutocrine signallingbusiness
researchProduct